Skip to main content
. Author manuscript; available in PMC: 2023 Jun 1.
Published in final edited form as: Ageing Res Rev. 2023 Mar 31;87:101923. doi: 10.1016/j.arr.2023.101923

Fig. 5.

Fig. 5.

IPD subgroup analyses of vitamin D3 supplementation and cancer mortality in the general population by age, sex, BMI, ethnicity, vitamin D baseline level, cancer diagnosis in five years prior baseline, and adherence in all trials (panel A, main analysis) and restricted to trials with a daily dosing regimen (panel B, post-hoc analysis). Note: No studies available for “Cancer diagnosis up to 5 years prior baseline” = yes.